Clinical pathways in China - an evaluation.

@article{He2015ClinicalPI,
  title={Clinical pathways in China - an evaluation.},
  author={Jingwei Alex 和經緯 He and Wei Yang},
  journal={International journal of health care quality assurance},
  year={2015},
  volume={28 4},
  pages={
          394-411
        }
}
PURPOSE Clinical pathways (CPs) are multidisciplinary care plans with essential care steps for patients with specific clinical problems. CPs were introduced in China in 2009 to assure quality, reduce risks, increase resource efficiency and control costs. The purpose of this paper is to present a Chinese public hospital case study where a CP pilot was undertaken to evaluate two main outcomes: length of stay and hospitalization costs for a tertiary hospital from 2010 to 2012 using a mixed-methods… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 44 REFERENCES

The impact of clinical pathways on quality management and control

Y. Jiao, R. Hu, M. Zhao
  • China Health Insurance,
  • 2013
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

An evaluation on the implementation of clinical pathway for capillary bronchitis

W. Zhang, Y. Dong
  • Guide of China Medicine,
  • 2014

Analysis on the clinical pathway for patients with cataract

S. Li, X. Fu
  • International Eye Sciences,
  • 2014

2013a), “The clinical pathway for total knee replacement and its effects on hospitalization costs

K. Wang, D. Peng, J. Lin
  • Chinese Health Economics,
  • 2013
VIEW 1 EXCERPT

An evaluation and analysis on the implementation of clinical pathways

Y. Zeng, J. Wang, +3 authors Q. Yu
  • Chinese Hospital Management,
  • 2013

Evaluation of clinical pathway for transient ischemic attack

J. Wang, D. Gong
  • Chinese Journal of Clinical Research,
  • 2013

Similar Papers

Loading similar papers…